Absorption Pharmaceuticals names CMO; CRN announces board; Blondel helms KitoZyme; Sabinsa Chairman Bammi dies; Doctor's Best hires supply chain VP; more People In Brief.

Absorption Pharmaceuticals names CMO; CRN announces board; Blondel helms KitoZyme; Sabinsa Chairman Bammi dies; Doctor's Best hires supply chain VP; more People In Brief.

Although prostate problems have plagued men for many years, the growing elderly population is now driving an unprecedented increase in caseloads and a corresponding need for improved treatments. One of the primary concerns is the rise in prostate cancer diagnoses. With more than two million American men currently living with prostate cancer and more than 200,000 new cases diagnosed each year, the market for diagnostic and therapeutic products to address this disease is substantial; more than $2 billion in the US in 2007.